Zepp Health (ZEPP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zepp Health reported a revenue of $42.5 million for Q3 2024, marking a 48.9% drop from the previous year, largely due to supply constraints and reduced sales of Xiaomi wearables. Despite a net loss, the company achieved the highest gross margin in its history, driven by successful new product launches like the Amazfit T-Rex 3. Zepp’s strategic focus on innovation and expanding its product line positions it for potential recovery and sustained growth.
For further insights into ZEPP stock, check out TipRanks’ Stock Analysis page.